Valuation (69%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 13.78 | 32.50 |
| PEG Ratio (TTM) | -1.42 | 5.87 |
| P/S Ratio (TTM) | 0.75 | 5.17 |
| P/B Ratio (TTM) | 0.92 | 9.42 |
| P/FCF Ratio (TTM) | 9.05 | 24.17 |
| Price to 5YR AVG Earnings Ratio | 34.59 | 33.57 |
| Price to 5YR AVG FCF Ratio | 84.68 | 75.53 |
Profitability (33%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 5.21% | 5.42% |
| ROE (TTM) | 6.89% | 21.15% |
| Net Profit Margin (TTM) | 5.44% | -28.14% |
| ROIC 5YR AVG | 1.18% | 91.95% |
Growth (65%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 7.10% | -61.11% | 1,182.18% |
| Revenue | -1.88% | 4.86% | 13.81% |
| Net Income | 7.01% | -61.00% | 1,192.47% |
| Cash Flow | 2,835.48% | 207.98% | 149.49% |
Health (65%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 3.30 | 1.99 |
| Quick Ratio (TTM) | 1.62 | 1.45 |
| D/E Ratio (TTM) | 0.06 | 1.29 |
| Interest Coverage (TTM) | 7.24 | 16.89 |
| Piotroski F-Score | 6 | 6 |
| Altman Z-Score | 3.30 | 4.36 |
| LTL to 5YR AVG FCF | 17.96 | 6.35 |
| Shares Outstanding Growth 5YR AVG | 0.59% | 11.16% |